marketcaparena
Search

    VVOS

    Vivos Therapeutics, Inc.

    Company overview

    Market capitalization
    $2.70M
    Employees
    270
    Latest publication
    2026-09-29
    About Vivos Therapeutics, Inc.

    Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue5,153,000USD5,141,000USD3,824,000USD6,783,000USD3,820,000USD3,016,000USD3,698,000USD3,860,000USD
    Cost Of Revenue2,200,000USD2,536,000USD836,000USD2,846,000USD1,710,000USD1,507,000USD1,601,000USD1,526,000USD
    Gross Profit2,953,000USD2,605,000USD2,988,000USD3,937,000USD2,110,000USD1,509,000USD2,097,000USD2,334,000USD
    Selling General Administrative7,113,000USD8,971,000USD8,928,000USD7,884,000USD6,409,000USD4,892,000USD4,347,000USD4,487,000USD
    Selling And Marketing Expenses155,000USD249,000USD—403,000USD260,000USD358,000USD412,000USD346,000USD
    General And Administrative Expenses7,113,000USD———————
    Total Operating Expenses7,778,000USD9,220,000USD10,206,000USD8,671,000USD6,975,000USD5,427,000USD4,903,000USD4,979,000USD
    Operating Income-4,825,000USD-6,615,000USD-6,382,000USD-4,734,000USD-4,865,000USD-3,918,000USD-2,806,000USD-2,645,000USD
    Total Other Income Expense Net-698,000USD-1,136,000USD-572,000USD-666,000USD-148,000USD54,000USD-21,000USD29,000USD
    Interest Expense1,100,000USD———————
    Income Before Tax-5,523,000USD-7,751,000USD-6,954,000USD-5,400,000USD-5,013,000USD-3,864,000USD-2,827,000USD-2,616,000USD
    Income Tax Expense0USD-69,000USD————-1,438,724USD-2,616,000USD
    Net Income-5,523,000USD-7,751,000USD-6,954,000USD-5,400,000USD-5,013,000USD-3,864,000USD-2,827,000USD-2,616,000USD
    Minority Interest-42,000USD69,000USD———0USD——
    Net Income Applicable To Common Shares-5,481,000USD———————
    Net Income From Continuing Ops—-7,751,000USD-6,954,000USD-5,400,000USD-5,013,000USD-3,864,000USD-2,827,000USD-2,616,000USD
    Ebit—-6,615,000USD—-4,734,000USD-4,865,000USD-3,918,000USD-2,806,000USD-2,645,000USD
    Ebitda—-6,161,000USD—-4,350,000USD-4,559,000USD-3,741,000USD-2,662,000USD-2,499,000USD
    Depreciation And Amortization—454,000USD—384,000USD306,000USD177,000USD144,000USD146,000USD
    Reconciled Depreciation—454,000USD442,000USD384,000USD306,000USD177,000USD144,000USD146,000USD
    Unclassified Operating Expenses——1,278,000USD—————
    Research Development——————100,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue17,443,000USD15,031,000USD13,801,000USD16,024,000USD16,885,000USD13,066,000USD11,393,277USD3,792,261USD
    Cost Of Revenue6,901,000USD6,012,000USD5,530,000USD6,005,000USD4,281,000USD2,653,000USD2,736,034USD1,081,641USD
    Gross Profit10,542,000USD9,019,000USD8,271,000USD10,019,000USD12,604,000USD10,413,000USD8,657,243USD2,710,620USD
    Selling General Administrative27,727,000USD17,878,000USD22,479,000USD29,041,000USD25,791,000USD16,090,000USD16,172,505USD9,272,890USD
    Selling And Marketing Expenses1,400,000USD1,731,000USD2,467,000USD5,340,000USD5,551,000USD2,314,000USD2,310,743USD1,163,239USD
    Unclassified Operating Expenses1,309,000USD————4,049,000USD——
    Total Operating Expenses30,436,000USD20,190,000USD25,567,000USD35,050,000USD32,075,000USD22,453,000USD19,234,476USD11,046,802USD
    Operating Income-19,894,000USD-11,171,000USD-17,296,000USD-25,031,000USD-19,471,000USD-12,040,000USD-10,577,233USD-8,336,182USD
    Income Before Tax-21,230,000USD-11,136,000USD-13,583,000USD-23,845,000USD-20,288,000USD-12,057,000USD-10,754,319USD-8,439,156USD
    Net Income-21,230,000USD-11,136,000USD-13,583,000USD-23,845,000USD-20,288,000USD-12,057,000USD-10,754,319USD-8,439,156USD
    Net Income From Continuing Ops-21,230,000USD-11,136,000USD-15,413,000USD-23,845,000USD-20,288,000USD-12,056,877USD-10,754,319USD-8,439,156USD
    Ebit-19,894,000USD-11,171,000USD-17,296,000USD-25,031,000USD-20,274,000USD-11,961,000USD-10,616,443USD-8,336,182USD
    Ebitda-18,585,000USD-10,590,000USD-16,675,000USD-24,362,000USD-19,541,000USD-11,243,000USD-9,865,215USD-7,725,509USD
    Depreciation And Amortization1,309,000USD581,000USD621,000USD669,000USD733,000USD718,000USD751,228USD610,673USD
    Reconciled Depreciation1,309,000USD581,000USD641,000USD669,000USD733,000USD717,865USD751,228USD610,673USD
    Total Other Income Expense Net-1,336,000USD35,000USD3,713,000USD1,186,000USD-817,000USD-17,000USD-177,086USD-102,974USD
    Research Development—100,000USD100,000USD200,000USD————
    Interest Expense———1,186,000USD14,000USD96,681USD137,876USD102,974USD
    Net Interest Income———0USD103,000USD-17,069USD-116,743USD-102,974USD
    Income Tax Expense———-1,186,000USD5,000USD-3,233,998USD137,876USD102,974USD
    Tax Provision———0USD0USD0USD0USD0USD
    Interest Income————117,000USD79,612USD21,133USD0USD
    Net Income Applicable To Common Shares————-20,288,000USD-17,987,795USD-11,754,319USD-9,439,156USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets24,144,000USD25,043,000USD25,152,000USD25,644,000USD26,033,000USD11,282,000USD15,284,000USD15,347,000USD
    Cash And Equivalents1,774,000USD———————
    Total Current Assets4,213,000USD4,819,000USD4,384,000USD5,786,000USD6,730,000USD3,607,000USD7,473,000USD7,399,000USD
    Other Current Assets1,001,000USD940,000USD774,000USD565,000USD695,000USD547,000USD783,000USD634,000USD
    Total Liabilities28,130,000USD———————
    Total Current Liabilities20,389,000USD17,937,000USD18,076,000USD7,437,000USD6,426,000USD4,701,000USD4,978,000USD5,126,000USD
    Other Current Liabilities1,200,000USD———————
    Other Non Current Liabilities950,000USD———————
    Total Stockholder Equity-3,815,000USD-1,138,000USD-1,490,000USD2,532,000USD4,583,000USD4,407,000USD7,954,000USD7,665,000USD
    Total Equity Including Noncontrolling Interest-3,986,000USD———————
    Short Long Term Debt7,772,000USD7,299,000USD8,353,000USD339,000USD157,000USD———
    Long Term Debt366,000USD418,000USD469,000USD8,379,000USD7,760,000USD———
    Deferred Revenue583,000USD———————
    Net Receivables1,438,000USD1,769,000USD1,581,000USD2,134,000USD1,633,000USD718,000USD430,000USD454,000USD
    Property Plant Equipment Net7,449,000USD7,559,000USD7,923,000USD9,025,000USD8,373,000USD4,259,000USD4,382,000USD4,446,000USD
    Goodwill8,572,000USD———————
    Intangible Assets3,638,000USD3,839,000USD4,045,000USD2,172,000USD2,225,000USD358,000USD370,000USD383,000USD
    Accounts Payable2,946,000USD1,996,000USD1,679,000USD2,103,000USD1,763,000USD1,206,000USD1,098,000USD1,075,000USD
    Short Term Debt790,000USD8,099,000USD—1,128,000USD866,000USD467,000USD477,000USD485,000USD
    Common Stock1,000USD1,000USD—1,000USD————
    Retained Earnings-138,520,000USD-133,039,000USD-125,357,000USD-118,464,000USD-113,064,000USD-108,051,000USD-104,187,000USD-101,360,000USD
    Total Liab—26,310,000USD26,702,000USD23,112,000USD21,450,000USD6,875,000USD7,330,000USD7,682,000USD
    Other Current Liab—7,842,000USD850,000USD4,206,000USD3,317,000USD2,456,000USD2,026,000USD2,253,000USD
    Capital Stock—1,000USD1,000USD1,000USD0USD0USD0USD0USD
    Good Will—8,572,000USD8,572,000USD8,450,000USD8,450,000USD2,843,000USD2,843,000USD2,843,000USD
    Cash—2,110,000USD2,029,000USD3,087,000USD4,402,000USD2,342,000USD6,260,000USD6,311,000USD
    Cash And Short Term Investments—2,110,000USD—3,087,000USD4,402,000USD2,342,000USD6,260,000USD6,311,000USD
    Current Deferred Revenue—479,000USD——480,000USD572,000USD896,000USD1,313,000USD
    Net Debt—10,158,000USD6,793,000USD9,411,000USD7,179,000USD-943,000USD-4,748,000USD-4,668,000USD
    Short Long Term Debt Total—12,268,000USD—12,498,000USD11,581,000USD1,399,000USD1,512,000USD1,643,000USD
    Property Plant Equipment Gross—10,743,000USD10,859,000USD12,056,000USD11,066,000USD6,687,000USD7,240,000USD7,172,000USD
    Common Stock Shares Outstanding—14,634,115shares9,286,609shares10,963,590shares9,087,202shares8,595,288shares5,889,520shares6,615,320shares
    Non Current Assets Total—20,224,000USD20,768,000USD19,858,000USD19,303,000USD7,675,000USD7,811,000USD7,948,000USD
    Non Current Liabilities Total—8,373,000USD8,626,000USD15,675,000USD15,024,000USD2,174,000USD2,352,000USD2,556,000USD
    Non Current Liabilities Other—1,300,000USD1,300,000USD1,400,000USD1,400,000USD———
    Non Currrent Assets Other—254,000USD228,000USD211,000USD255,000USD215,000USD216,000USD276,000USD
    Net Working Capital—-13,118,000USD-13,692,000USD-1,651,000USD304,000USD-1,094,000USD2,495,000USD2,273,000USD
    Unclassified Current Liabilities—-7,778,000USD7,194,000USD—————
    Unclassified Non Current Liabilities—6,655,000USD6,857,000USD5,896,000USD5,864,000USD2,174,000USD2,352,000USD2,556,000USD
    Unclassified Equity—131,899,000USD123,866,000USD120,994,000USD117,647,000USD112,458,000USD112,141,000USD109,025,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets25,152,000USD15,284,000USD10,730,000USD13,720,000USD33,689,000USD25,327,469USD7,551,537USD8,203,967USD
    Intangible Assets4,045,000USD370,000USD420,000USD302,000USD341,000USD270,121USD689,151USD1,140,276USD
    Other Current Assets774,000USD783,000USD616,000USD1,448,000USD1,575,000USD673,061USD295,000USD161,686USD
    Total Liab26,702,000USD7,330,000USD10,319,000USD8,919,000USD8,150,000USD8,410,110USD10,494,596USD3,377,174USD
    Total Stockholder Equity-1,490,000USD7,954,000USD411,000USD4,801,000USD25,539,000USD16,917,359USD-2,943,059USD4,826,793USD
    Other Current Liab6,838,000USD2,026,000USD2,205,000USD2,057,000USD2,856,000USD3,237,085USD1,353,161USD632,021USD
    Common Stock1,000USD——2,000USD2,000USD2,000USD1,244USD1,207USD
    Capital Stock1,000USD0USD0USD2,000USD2,000USD1,821USD1,244USD1,207USD
    Retained Earnings-125,357,000USD-104,187,000USD-93,051,000USD-79,468,000USD-55,623,000USD-35,334,728USD-23,277,851USD-12,523,532USD
    Good Will8,572,000USD2,843,000USD2,843,000USD2,843,000USD2,843,000USD2,671,434USD2,671,434USD3,743,521USD
    Cash2,029,000USD6,260,000USD1,643,000USD3,519,000USD24,030,000USD18,205,668USD469,353USD1,254,723USD
    Cash And Short Term Investments2,029,000USD6,260,000USD1,643,000USD3,519,000USD24,030,000USD18,205,668USD469,353USD1,254,723USD
    Total Current Assets4,384,000USD7,473,000USD2,461,000USD5,424,000USD27,324,000USD20,394,315USD1,984,155USD2,011,596USD
    Total Current Liabilities18,076,000USD4,978,000USD7,289,000USD6,813,000USD7,509,000USD7,823,049USD9,093,683USD2,157,157USD
    Current Deferred Revenue479,000USD896,000USD2,138,000USD2,926,000USD2,399,000USD2,937,992USD2,947,565USD889,508USD
    Net Debt11,473,000USD-4,748,000USD352,000USD-1,106,000USD-22,398,000USD-16,915,601USD3,240,182USD-568,178USD
    Short Term Debt9,080,000USD477,000USD474,000USD419,000USD1,334,000USD866,972USD3,709,535USD161,545USD
    Short Long Term Debt8,353,000USD———1,265,000USD866,972USD3,709,535USD161,545USD
    Short Long Term Debt Total13,502,000USD1,512,000USD1,995,000USD2,413,000USD1,632,000USD1,290,067USD3,709,535USD686,545USD
    Long Term Debt469,000USD————423,095USD—525,000USD
    Net Receivables1,581,000USD430,000USD202,000USD457,000USD1,719,000USD1,515,586USD955,986USD595,187USD
    Accounts Payable1,679,000USD1,098,000USD2,145,000USD1,411,000USD920,000USD781,000USD1,083,422USD474,083USD
    Property Plant Equipment Net7,923,000USD4,382,000USD4,699,000USD4,777,000USD2,825,000USD871,597USD1,139,501USD1,281,668USD
    Property Plant Equipment Gross10,859,000USD7,240,000USD7,025,000USD6,530,000USD4,068,000USD871,597USD1,139,501USD1,281,668USD
    Common Stock Shares Outstanding10,273,881shares5,019,886shares1,219,381shares920,484shares849,320shares728,378shares496,427shares461,926shares
    Non Current Assets Total20,768,000USD7,811,000USD8,269,000USD8,296,000USD6,365,000USD4,933,154USD5,567,382USD6,192,371USD
    Non Current Liabilities Total8,626,000USD2,352,000USD3,030,000USD2,106,000USD641,000USD587,061USD1,400,913USD1,220,017USD
    Non Current Liabilities Other1,300,000USD———————
    Non Currrent Assets Other228,000USD216,000USD307,000USD374,000USD356,000USD1,120,000USD1,067,296USD26,906USD
    Net Working Capital-13,692,000USD2,495,000USD-4,828,000USD-1,389,000USD19,815,000USD12,571,266USD-7,109,528USD-145,561USD
    Unclassified Current Liabilities-8,353,000USD———-1,265,000USD—-3,709,535USD—
    Unclassified Non Current Liabilities6,857,000USD2,352,000USD3,030,000USD2,106,000USD——1,316,667USD—
    Unclassified Equity123,865,000USD112,141,000USD93,462,000USD84,265,000USD81,158,000USD53,748,266USD21,648,971USD18,014,578USD
    Inventory——1USD—-516,000USD1USD263,814USD1USD
    Other Liab————641,000USD163,966USD84,246USD28,350USD
    Other Assets————356,000USD1,120,002USD1,067,296USD26,906USD
    Accumulated Other Comprehensive Income————0USD-1,500,000USD-1,316,667USD-666,667USD
    Net Tangible Assets————22,355,000USD13,975,804USD-6,303,644USD-57,004USD
    Unclassified Non Current Assets—————-1,120,000USD-1,067,296USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation965,000USD
    Stock Based Compensation201,000USD
    Change To Account Receivables143,000USD
    Change To Liabilities2,321,000USD
    Change In Working Capital1,183,000USD
    Operating Cash Flow-9,158,000USD
    Capital Expenditures-434,000USD
    Investing Cash Flow-434,000USD
    Net Debt Issuance2,997,000USD
    Unclassified Financing Cash Flow6,340,000USD
    Financing Cash Flow9,337,000USD
    Change In Cash-255,000USD
    End Cash Flow1,774,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-7,751,000USD-6,894,000USD-5,399,000USD-5,013,000USD-3,864,000USD-2,827,000USD-2,617,000USD-1,930,000USD
    Depreciation454,000USD442,000USD384,000USD306,000USD177,000USD144,000USD146,000USD145,000USD
    Stock Based Compensation151,000USD47,000USD55,000USD242,000USD317,000USD57,000USD142,000USD270,000USD
    Other Non Cash Items654,000USD—1,244,000USD100,000USD—5,000USD-2,615,000USD26,000USD
    Change To Account Receivables-188,000USD553,000USD-501,000USD19,000USD-288,000USD24,000USD-59,000USD131,000USD
    Change In Working Capital482,000USD2,753,000USD799,000USD871,000USD-426,000USD-319,000USD757,000USD-1,559,000USD
    Total Cash From Operating Activities-6,010,000USD-3,812,000USD-4,161,000USD-3,494,000USD-3,796,000USD-2,940,000USD-4,187,000USD-3,048,000USD
    Capital Expenditures-18,000USD-1,531,000USD893,000USD-771,000USD-122,000USD-165,000USD-211,000USD-60,000USD
    Free Cash Flow-6,010,000USD-5,343,000USD-3,268,000USD-4,265,000USD-3,918,000USD-3,105,000USD-3,976,000USD-3,108,000USD
    Total Cashflows From Investing Activities-18,000USD—83,000USD-5,906,000USD-122,000USD-165,000USD-192,000USD-60,000USD
    Net Borrowings980,000USD1,534,000USD-531,000USD9,642,000USD0USD—0USD—
    Total Cash From Financing Activities6,109,000USD4,335,000USD2,763,000USD11,460,000USD0USD3,054,000USD3,787,000USD7,400,000USD
    Issuance Of Capital Stock342,000USD2,801,000USD2,428,000USD347,000USD0USD3,500,000USD4,296,000USD—
    Change In Cash81,000USD-1,058,000USD-1,315,000USD2,060,000USD-3,918,000USD-51,000USD-592,000USD4,292,000USD
    Begin Period Cash Flow2,029,000USD3,087,000USD4,402,000USD2,342,000USD6,260,000USD6,311,000USD6,903,000USD2,611,000USD
    End Period Cash Flow2,110,000USD2,029,000USD3,087,000USD4,402,000USD2,342,000USD6,260,000USD6,311,000USD6,903,000USD
    Other Cashflows From Investing Activities-638,000USD—-5,945,000USD—-122,000USD-165,000USD-403,000USD-803,000USD
    Other Cashflows From Financing Activities6,109,000USD—2,763,000USD——-446,000USD3,787,000USD7,400,000USD
    Unclassified Financing Cash Flow-1,322,000USD—-1,897,000USD1,471,000USD——-4,296,000USD—
    Investments——83,000USD-5,906,000USD-122,000USD-165,000USD-192,000USD-60,000USD
    Unclassified Operating Cash Flow——-1,244,000USD—————
    Unclassified Investing Cash Flow——5,052,000USD—————
    Change To Inventory———————-662,000USD
    Sale Purchase Of Stock———————-116,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-21,230,000USD-11,136,000USD-13,583,000USD-23,845,000USD-20,288,000USD-12,056,877USD-10,754,319USD-8,439,156USD
    Depreciation1,309,000USD581,000USD621,000USD669,000USD733,000USD717,865USD751,228USD610,673USD
    Stock Based Compensation661,000USD762,000USD924,000USD2,396,000USD2,658,000USD2,172,197USD1,987,275USD1,283,156USD
    Other Non Cash Items3,997,000USD42,000USD-2,772,000USD-518,000USD-9,000USD3,917,596USD83,068USD364,338USD
    Change To Account Receivables-217,000USD-228,000USD255,000USD746,000USD228,000USD-559,600USD-276,103USD-530,289USD
    Change In Working Capital3,997,000USD-2,940,000USD2,864,000USD1,711,000USD28,000USD-431,075USD2,531,925USD867,098USD
    Total Cash From Operating Activities-15,263,000USD-12,691,000USD-11,946,000USD-19,587,000USD-15,735,000USD-5,680,294USD-5,340,480USD-5,313,891USD
    Capital Expenditures-2,341,000USD-568,000USD-803,000USD-924,000USD-2,396,000USD-120,252USD-175,599USD-1,250,591USD
    Free Cash Flow-17,604,000USD-13,259,000USD-12,749,000USD-20,511,000USD-18,131,000USD-5,800,546USD-5,516,079USD-6,564,482USD
    Total Cashflows From Investing Activities-7,526,000USD-568,000USD-853,000USD-924,000USD-2,608,000USD-120,252USD86,223USD-1,117,254USD
    Net Borrowings10,645,000USD0USD—0USD-25,000USD1,190,067USD3,730,275USD-88,236USD
    Total Cash From Financing Activities18,558,000USD17,876,000USD10,923,000USD7,355,000USD24,167,000USD23,536,861USD4,468,887USD5,253,031USD
    Issuance Of Capital Stock5,576,000USD7,796,000USD8,000,000USD8,000,000USD27,930,000USD24,742,000USD1,248,499USD6,353,732USD
    Change In Cash-4,231,000USD4,617,000USD-1,876,000USD-20,511,000USD5,824,000USD17,736,315USD-785,370USD-1,178,114USD
    Begin Period Cash Flow6,260,000USD1,643,000USD3,519,000USD24,030,000USD18,206,000USD469,353USD1,254,723USD2,432,837USD
    End Period Cash Flow2,029,000USD6,260,000USD1,643,000USD3,519,000USD24,030,000USD18,205,668USD469,353USD1,254,723USD
    Other Cashflows From Investing Activities-7,526,000USD-568,000USD—-924,000USD13,000USD13,000USD11,822USD11,822USD
    Other Cashflows From Financing Activities18,558,000USD10,080,000USD-1,077,000USD-924,000USD-3,738,000USD7,189,928USD7,359,183USD-1,012,465USD
    Unclassified Operating Cash Flow-3,997,000USD———1,143,000USD———
    Unclassified Investing Cash Flow2,341,000USD1,136,000USD—1,848,000USD2,383,000USD——1,238,769USD
    Unclassified Financing Cash Flow-16,221,000USD—4,000,000USD8,279,000USD29,430,000USD21,024,433USD-2,511,036USD7,353,732USD
    Investments—-568,000USD-888,000USD-924,000USD-2,608,000USD-120,252USD86,223USD-1,117,254USD
    Sale Purchase Of Stock———0USD-1,500,000USD-2,150,000USD-350,000USD-1,000,000USD
    Change To Inventory————168,000USD332,591USD401,015USD—
    Change To Liabilities————-400,000USD-283,785USD2,605,677USD1,125,143USD
    Dividends Paid—————-3,717,567USD-3,759,535USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductAppliances422,000USD0001493152-26-024650
    Q1 2026Quarterly · 2026-03-31ProductBilling Intelligence Services145,000USD0001493152-26-024650
    Q1 2026Quarterly · 2026-03-31ProductMyofunctional Therapy Services125,000USD0001493152-26-024650
    Q1 2026Quarterly · 2026-03-31ProductSleep Testing Services2,296,000USD0001493152-26-024650
    Q1 2026Quarterly · 2026-03-31ProductSponsorship Seminar Other205,000USD0001493152-26-024650
    Q1 2026Quarterly · 2026-03-31ProductTooth Positioners1,018,000USD0001493152-26-024650
    Q1 2026Quarterly · 2026-03-31ProductTreatment Centers892,000USD0001493152-26-024650
    Q1 2026Quarterly · 2026-03-31ProductVIP37,000USD0001493152-26-024650
    FY 2025Yearly · 2025-12-31ProductAppliances3,277,000USD0001493152-26-016854
    FY 2025Yearly · 2025-12-31ProductBilling Intelligence Services686,000USD0001493152-26-016854
    FY 2025Yearly · 2025-12-31ProductMyofunctional Therapy Services337,000USD0001493152-26-016854
    FY 2025Yearly · 2025-12-31ProductSleep Testing Services6,041,000USD0001493152-26-016854
    FY 2025Yearly · 2025-12-31ProductSponsorship Seminar Other1,222,000USD0001493152-26-016854
    FY 2025Yearly · 2025-12-31ProductTooth Positioners3,210,000USD0001493152-26-016854
    FY 2025Yearly · 2025-12-31ProductTreatment Centers2,179,000USD0001493152-26-016854
    FY 2025Yearly · 2025-12-31ProductVIP491,000USD0001493152-26-016854
    Q3 2025Quarterly · 2025-09-30ProductAppliances1,405,000USD0001493152-25-024253
    Q3 2025Quarterly · 2025-09-30ProductBilling Intelligence Services184,000USD0001493152-25-024253
    Q3 2025Quarterly · 2025-09-30ProductGuides790,000USD0001493152-25-024253
    Q3 2025Quarterly · 2025-09-30ProductMyofunctional Therapy Services205,000USD0001493152-25-024253
    Q3 2025Quarterly · 2025-09-30ProductSleep Testing Services2,560,000USD0001493152-25-024253
    Q3 2025Quarterly · 2025-09-30ProductSponsorship Seminar Other236,000USD0001493152-25-024253
    Q3 2025Quarterly · 2025-09-30ProductTreatment Centers1,321,000USD0001493152-25-024253
    Q3 2025Quarterly · 2025-09-30ProductVIP82,000USD0001493152-25-024253
    Q2 2025Quarterly · 2025-06-30ProductAppliances1,028,000USD0001641172-25-024832
    Q2 2025Quarterly · 2025-06-30ProductBilling Intelligence Services190,000USD0001641172-25-024832
    Q2 2025Quarterly · 2025-06-30ProductGuides857,000USD0001641172-25-024832
    Q2 2025Quarterly · 2025-06-30ProductMyofunctional Therapy Services163,000USD0001641172-25-024832
    Q2 2025Quarterly · 2025-06-30ProductSleep Testing Services844,000USD0001641172-25-024832
    Q2 2025Quarterly · 2025-06-30ProductSponsorship Seminar Other608,000USD0001641172-25-024832
    Q2 2025Quarterly · 2025-06-30ProductVIP130,000USD0001641172-25-024832
    Q1 2025Quarterly · 2025-03-31ProductAppliances1,273,000USD0001493152-26-024650
    Q1 2025Quarterly · 2025-03-31ProductBilling Intelligence Services181,000USD0001493152-26-024650
    Q1 2025Quarterly · 2025-03-31ProductMyofunctional Therapy Services148,000USD0001493152-26-024650
    Q1 2025Quarterly · 2025-03-31ProductSleep Testing Services323,000USD0001493152-26-024650
    Q1 2025Quarterly · 2025-03-31ProductSponsorship Seminar Other328,000USD0001493152-26-024650
    Q1 2025Quarterly · 2025-03-31ProductTooth Positioners540,000USD0001493152-26-024650
    Q1 2025Quarterly · 2025-03-31ProductVIP223,000USD0001493152-26-024650
    FY 2024Yearly · 2024-12-31ProductAppliances5,601,000USD0001493152-26-016854
    FY 2024Yearly · 2024-12-31ProductBilling Intelligence Services840,000USD0001493152-26-016854
    FY 2024Yearly · 2024-12-31ProductMyofunctional Therapy Services609,000USD0001493152-26-016854
    FY 2024Yearly · 2024-12-31ProductSleep Testing Services1,282,000USD0001493152-26-016854
    FY 2024Yearly · 2024-12-31ProductSponsorship Seminar Other1,941,000USD0001493152-26-016854
    FY 2024Yearly · 2024-12-31ProductTooth Positioners2,273,000USD0001493152-26-016854
    FY 2024Yearly · 2024-12-31ProductVIP2,485,000USD0001493152-26-016854
    Q3 2024Quarterly · 2024-09-30ProductAppliances1,583,000USD0001493152-25-024253
    Q3 2024Quarterly · 2024-09-30ProductBilling Intelligence Services206,000USD0001493152-25-024253
    Q3 2024Quarterly · 2024-09-30ProductGuides375,000USD0001493152-25-024253
    Q3 2024Quarterly · 2024-09-30ProductMyofunctional Therapy Services147,000USD0001493152-25-024253
    Q3 2024Quarterly · 2024-09-30ProductSleep Testing Services329,000USD0001493152-25-024253
    Q3 2024Quarterly · 2024-09-30ProductSponsorship Seminar Other294,000USD0001493152-25-024253
    Q3 2024Quarterly · 2024-09-30ProductVIP926,000USD0001493152-25-024253
    Q2 2024Quarterly · 2024-06-30ProductAppliances1,576,000USD0001641172-25-024832
    Q2 2024Quarterly · 2024-06-30ProductBilling Intelligence Services213,000USD0001641172-25-024832
    Q2 2024Quarterly · 2024-06-30ProductGuides399,000USD0001641172-25-024832
    Q2 2024Quarterly · 2024-06-30ProductMyofunctional Therapy Services150,000USD0001641172-25-024832
    Q2 2024Quarterly · 2024-06-30ProductSleep Testing Services318,000USD0001641172-25-024832
    Q2 2024Quarterly · 2024-06-30ProductSponsorship Seminar Other224,000USD0001641172-25-024832
    Q2 2024Quarterly · 2024-06-30ProductVIP1,174,000USD0001641172-25-024832
    Q1 2024Quarterly · 2024-03-31ProductAppliances1,145,000USD0001641172-25-010874
    Q1 2024Quarterly · 2024-03-31ProductBilling Intelligence Services225,000USD0001641172-25-010874
    Q1 2024Quarterly · 2024-03-31ProductGuides529,000USD0001641172-25-010874
    Q1 2024Quarterly · 2024-03-31ProductMyofunctional Therapy Services184,000USD0001641172-25-010874
    Q1 2024Quarterly · 2024-03-31ProductSleep Testing Services307,000USD0001641172-25-010874
    Q1 2024Quarterly · 2024-03-31ProductSponsorship Seminar Other122,000USD0001641172-25-010874
    Q1 2024Quarterly · 2024-03-31ProductVIP907,000USD0001641172-25-010874
    FY 2023Yearly · 2023-12-31ProductAppliances6,081,000USD0001641172-25-001750
    FY 2023Yearly · 2023-12-31ProductBilling Intelligence Services887,000USD0001641172-25-001750
    FY 2023Yearly · 2023-12-31ProductGuides189,000USD0001641172-25-001750
    FY 2023Yearly · 2023-12-31ProductMyofunctional Therapy Services861,000USD0001641172-25-001750
    FY 2023Yearly · 2023-12-31ProductSleep Testing Services1,185,000USD0001641172-25-001750
    FY 2023Yearly · 2023-12-31ProductSponsorship Seminar Other676,000USD0001641172-25-001750
    FY 2023Yearly · 2023-12-31ProductVIP3,922,000USD0001641172-25-001750
    Q3 2023Quarterly · 2023-09-30ProductAppliances1,195,000USD0001493152-24-045888
    Q3 2023Quarterly · 2023-09-30ProductBilling Intelligence Services218,000USD0001493152-24-045888
    Q3 2023Quarterly · 2023-09-30ProductGuides271,000USD0001493152-24-045888
    Q3 2023Quarterly · 2023-09-30ProductMyofunctional Therapy Services228,000USD0001493152-24-045888
    Q3 2023Quarterly · 2023-09-30ProductSleep Testing Services308,000USD0001493152-24-045888
    Q3 2023Quarterly · 2023-09-30ProductSponsorship Seminar Other101,000USD0001493152-24-045888
    Q3 2023Quarterly · 2023-09-30ProductVIP980,000USD0001493152-24-045888
    FY 2022Yearly · 2022-12-31ProductAppliance Sales To VIP7,820,000USD0001493152-24-011755
    FY 2022Yearly · 2022-12-31ProductBilling Intelligence Services1,170,000USD0001493152-24-011755
    FY 2022Yearly · 2022-12-31ProductBIS100,000USD0001493152-24-011755
    FY 2022Yearly · 2022-12-31ProductCenter Revenue561,000USD0001493152-24-011755
    FY 2022Yearly · 2022-12-31ProductMyofunctional Therapy Services927,000USD0001493152-24-011755
    FY 2022Yearly · 2022-12-31ProductSleep Testing Services594,000USD0001493152-24-011755
    FY 2022Yearly · 2022-12-31ProductSponsorship Seminar Other114,000USD0001493152-24-011755
    FY 2022Yearly · 2022-12-31ProductVIP4,838,000USD0001493152-24-011755
    FY 2021Yearly · 2021-12-31ProductAppliance Sales To VIP6,040,000USD0001493152-23-009765
    FY 2021Yearly · 2021-12-31ProductBilling Intelligence Services905,000USD0001493152-23-009765
    FY 2021Yearly · 2021-12-31ProductCenter Revenue480,000USD0001493152-23-009765
    FY 2021Yearly · 2021-12-31ProductManagement Service Revenue313,000USD0001493152-23-009765
    FY 2021Yearly · 2021-12-31ProductMyofunctional Therapy Services341,000USD0001493152-23-009765
    FY 2021Yearly · 2021-12-31ProductSponsorship Seminar Other289,000USD0001493152-23-009765
    FY 2021Yearly · 2021-12-31ProductVIP8,517,000USD0001493152-23-009765
    FY 2020Yearly · 2020-12-31ProductAppliance Sales To VIP4,548,000USD0001493152-22-008452
    FY 2020Yearly · 2020-12-31ProductBilling Intelligence Services620,000USD0001493152-22-008452
    FY 2020Yearly · 2020-12-31ProductCenter Revenue342,000USD0001493152-22-008452
    FY 2020Yearly · 2020-12-31ProductSponsorship Seminar Other15,000USD0001493152-22-008452
    FY 2020Yearly · 2020-12-31ProductVIP7,541,000USD0001493152-22-008452

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.